Stockhub

Enlivex Therapeutics Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

26 August 2022

  • curprev 05:5805:58, 26 August 2022 >Nick 500 bytes +500 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel. == References and notes == Ca..."
Retrieved from "https://stockhub.co/research/Enlivex_Therapeutics_Ltd."